TG Therapeutics (TGTX)
NASDAQ:TGTX
Holding TGTX?
Track your performance easily

TG Therapeutics (TGTX) Financial Statements

1,687 Followers

TG Therapeutics Financial Overview

TG Therapeutics's market cap is currently ―. The company's EPS TTM is $0.6; its P/E ratio is 39.54; TG Therapeutics is scheduled to report earnings on November 12, 2024, and the estimated EPS forecast is $0.02. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 73.47M$ 63.47M$ 43.97M$ 165.81M$ 16.04M
Gross Profit$ 65.16M$ 58.03M$ 36.12M$ 162.31M$ 16.07M
EBIT$ 6.55M$ -8.39M$ -11.60M$ 136.01M$ -29.53M
EBITDA$ 7.76M$ -8.31M$ -11.50M$ 136.78M$ -28.81M
Net Income Common Stockholders$ 6.88M$ -10.71M$ -14.42M$ 132.30M$ -47.61M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 217.25M$ 209.78M$ 217.51M$ 229.16M$ 144.91M
Total Assets$ 401.21M$ 373.32M$ 329.59M$ 331.07M$ 220.85M
Total Debt$ 112.54M$ 111.67M$ 110.80M$ 109.91M$ 109.02M
Net Debt$ -104.71M$ -98.12M$ -106.71M$ -119.25M$ -35.89M
Total Liabilities$ 223.64M$ 213.21M$ 169.09M$ 166.30M$ 180.40M
Stockholders Equity$ 177.57M$ 160.11M$ 160.50M$ 164.77M$ 40.45M
Cash Flow-
Free Cash Flow$ 5.54M$ -8.21M$ -13.21M$ 83.70M$ -42.48M
Operating Cash Flow$ 5.54M$ -8.21M$ -13.21M$ 83.70M$ -42.48M
Investing Cash Flow$ 1.76M$ -9.26M$ -44.76M$ -30.23M$ 31.00M
Financing Cash Flow$ 135.00K$ 10.00K$ -1.00K$ 421.00K$ 47.05M
Currency in USD

TG Therapeutics Earnings and Revenue History

TG Therapeutics Debt to Assets

TG Therapeutics Cash Flow

TG Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis